Clinical Trials Directory

Trials / Completed

CompletedNCT06060145

Effect of Indoor Plants on Cardiopulmonary System

Effect of Indoor Plants on Cardiopulmonary System: a Randomized, Crossover, Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Lina Zhang · Other Government
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

This is a randomized controlled human exposure crossover study, aims to explore the health benefits of indoor plants on cardiopulmonary system on adults.

Detailed description

The researchers will conduct a randomized cross-controlled trial involving 48 healthy adults in Hangzhou, China. These participants will be randomly assigned into two groups, each comprising 24 individuals. Each participant will undergo two separate exposures in an office setting: one exposure without any plants present, and another exposure with 34 to 38 potted plants. A washout period of at least 4 weeks will be implemented between the two exposures. Questionnaires, physical examinations and the collection of biological samples will be conducted prior to exposure and after exposure. In addition, the monitoring of negative air ion, air pollutants and noise exposure, as well as collection of environmental microbial samples, will be conducted on weekdays. Researchers will gather samples of blood, urine, nasal secretion, and exhaled breath condensate from participants.

Conditions

Interventions

TypeNameDescription
OTHERPlants placed in an office environmentThe intervention group will be provided with an intervention consisting of 34-38 potted plants arranged in an office environment for a duration of 8 hours (09:00-17:00) on weekdays (Monday to Friday) for 4 weeks.
OTHERDevoid of any plant presence in an office environmentParticipants assigned to the control group will be exposed to an office environment devoid of any plant presence for a duration of 8 hours (09:00-17:00) on weekdays (Monday to Friday) for 4 weeks.

Timeline

Start date
2023-12-21
Primary completion
2024-03-29
Completion
2024-03-31
First posted
2023-09-29
Last updated
2024-07-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06060145. Inclusion in this directory is not an endorsement.